IMU - Imuniti - Clinical trials on Imuniti wellness pack have started
IMU
IMU
IMU - Imuniti - Clinical trials on Imuniti wellness pack have started
Imuniti Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 2004/002282/06)
(JSE Code: IMU & ISIN: ZAE000089199)
("Imuniti" or "the company" or "the group")
Clinical Trials on Imuniti Wellness Pack have started
Further to the SENS announcements made on the 13 December 2007 and 28 May 2008,
Imuniti is pleased to advise that the long awaited medical trials of the Imuniti
Wellness Pack have commenced.
Imuniti has received confirmation from Dr. Gilbert Matsabisa of the Medical
Research Council that phase one, being clinical safety trials on humans, has
commenced.
On behalf of the Board:
P. Fouche J. Barnard
Chief Executive Officer Chief Operating Officer
27 August 2008
Designated Adviser: Exchange Sponsors (Pty) Limited
Date: 27/08/2008 09:58:03 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
